Logo
x

Search

Subscribe Now

indication

Roche to Withdraw Tecentriq Indication in Metastatic Bladder Cancer in the US

Roche to Withdraw Tecentriq Indication in Metastatic Bladder Cancer in the US

  • March 8, 2021
Pfizer's Lorbrena (lorlatinib) Receives FDA's Approval for Expanding its Indication to Treat ALK-Positive Metastatic Lung Cancer

Pfizer's Lorbrena (lorlatinib) Receives FDA's Approval for Expanding its Indication to Treat ALK-Positive Metastatic Lung Cancer

  • March 4, 2021
AbbVie and Eisai's Humira (adalimumab) Receives MHLW's Approval for Pyoderma Gangrenosum

AbbVie and Eisai's Humira (adalimumab) Receives MHLW's Approval for Pyoderma Gangrenosum

  • November 30, 2020
BeyondSpring's Plinabulin Receives the US FDA's and NMPA's Breakthrough Therapy Designations for Chemotherapy-Induced Neutropenia Indication

BeyondSpring's Plinabulin Receives the US FDA's and NMPA's Breakthrough Therapy Designations for Chemotherapy-Induced Neutropenia...

  • September 8, 2020
Chipscreen Bioscience's Epidaza (chidamide) Receives NMPA Approval for Breast Cancer Indication

Chipscreen Bioscience's Epidaza (chidamide) Receives NMPA Approval for Breast Cancer Indication

  • December 2, 2019
Samsung Bioepis Eticovo's (etanercept-ykro- biosmilar) Receives FDA's Approval for All Eligible Indication

Samsung Bioepis Eticovo's (etanercept-ykro- biosmilar) Receives FDA's Approval for All Eligible Indication

  • April 29, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.